Shares of Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) fell 8.1% during trading on Thursday . The stock traded as low as $1.41 and last traded at $1.47. 738 shares changed hands during trading, a decline of 90% from the average session volume of 7,096 shares. The stock had previously closed at $1.60.
Nutriband Price Performance
The company’s 50-day simple moving average is $1.51 and its 200-day simple moving average is $1.31.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Read More
- Five stocks we like better than Nutriband
- What is a SEC Filing?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Invest in Insurance Companies: A Guide
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20220621071932&h=45&w=95&zc=2){kind=logo}
